Funding
Series B · Biotech

Draig Therapeutics raises $65M Series B

Draig Therapeutics raised $65 million in Series B financing announced in July.

Updated Oct 16, 2026By RoundOS Funding desk

Deep Track Capital, Janus Henderson Investors, Marshall Wace, British Business Bank, Jefferson Life Sciences, SV Health Investors, ICG, Access Biotechnology, Canaan Partners, SR One, Sanofi Ventures and Schroders Capital are among its backers.

The company develops neuropsychiatric medicines.

Funding history

Series B · This round$65M

Sources

  1. Draig Therapeuticsprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026
Cognitive Credit

Cognitive Credit provides corporate credit data, financial models and AI analysis tools for investment banks and asset managers.

$40MStrategic growth investment · Oct 22, 2026

Related